ERG and prostate neoplasm: More recent chromatin immunoprecipitation sequencing studies have confirmed that AR binds to the FASN promoter region in primary prostate tumors, with particular enrichment in tumors from self-identified Black (BL) men (13), and the increased expression of FASN in ERG-rearranged tumors may also be consistent with a role for AR in FASN regulation (14).